CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- 4 Planned sale Chief Regulatory Officer sold 103,480 shares at $3.02 ($312,510)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K12B Other 8-K12B
- 8-K Event Regulation FD disclosure
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Conversion Director acquired 3,823,996 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 21 · 404 filings